Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 119, Issue 2, 2001, Pages 248-260

  Penkowa, Milena ^a   Espejo, Carmen ^b   Martínez Cáceres, Eva M ^b   Poulsen, Christian Bjorn ^a   Montalban, Xavier ^b   Hidalgo, Juan ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Apoptosis; Cytokines; EAE MS; Metallothionein (MT); Oxidative stress

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; METALLOTHIONEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; INFECTION SENSITIVITY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLIOSIS; IN SITU NICK-END LABELING; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES; MALONDIALDEHYDE; METALLOTHIONEIN; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICROGLIA; NERVE DEGENERATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 0035479008     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00357-5     Document Type: Article

References (81)

1. Apoptosis in multiple sclerosis. Etiopathogenetic relevance and prospects for new therapeutic strategies
2. Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons
3. Axonal damage in multiple sclerosis
4. The functional significance of brain metallothioneins
5. Astrocytic functions and physiological reactions to injury: The potential to induce and/or exacerbate neuronal dysfunction - A forum position paper
6. Metallothionein (MT) isoforms in the central nervous system (CNS): Regional and cell-specific distribution and potential functions as an antioxidant
7. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
8. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
9. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis
10. Mechanisms of immune injury in multiple sclerosis
11. Structural and functional impact of the transgenic expression of cytokines in the CNS
12. Transgenic mice and cytokine actions in the brain: Bridging the gap between structural and functional neuropathology
13. Enhanced seizures and hippocampal neurodegeneration following kainic acid induced seizures in metallothionein-I+II deficient mice
14. An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
15. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice
16. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis
17. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice
18. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis
19. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease
20. Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells
21. Differential expression of metallothioneins in the central nervous system of mice with experimental autoimmune encephalomyelitis
22. Development of a competitive double antibody radioimmunoassay for rat metallothionein
23. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation
24. Selective degeneration of oligodendrocytes mediated by oxygen radical species
25. Regulation of brain metallothioneins
26. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination
27. Some pathophysiological aspects of experimental autoimmune encephalomyelitis
28. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor
29. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase
30. TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: An overview
31. Effect of reactive oxygen species on myelin membrane proteins
32. Effect of non-toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide-induced activation
33. The pathology of multiple sclerosis and its evolution
34. Metallothioneins and cell death by anticancer drugs
35. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes
36. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs
37. Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc
38. Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: Effects of macrophage enrichment
39. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells
40. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites
41. Targeted disruption of metallothionein I and II genes increased sensitivity to cadmium
42. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice
43. Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression
44. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
45. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis
46. IL-6 deficiency leads to reduced metallothionein I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment
47. Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis
48. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-α and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE)
49. Increased astrocytic expression of metallothioneins I+II in brain stem of adult rats treated with 6-aminonicotinamide
50. CNS wound healing is severely depressed in metallothionein-I and II-deficient mice
51. Impaired inflammatory response to glial cell death in genetically metallothionein-I+II deficient mice
52. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice
53. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice
54. Overexpression of metallothionein decreases sensitivity of pulmonary endothelial cells to oxidant injury
55. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: Modulation by oral administration of myelin basic protein
56. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha
57. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1
58. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
59. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis
60. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines
61. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats
62. Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease
63. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
64. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor
65. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide
66. Reactive oxygen species in experimental allergic encephalomyelitis
67. Oxidative stress and neurodegenerative disorders
68. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease
69. Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase
70. Differential role of TNF-alpha and IFN-gamma in the brain of rats with chronic relapsing autoimmune encephalomyelitis
71. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells
72. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system
73. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals
74. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin
75. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia
76. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist
77. Cytokine production in the central nervous system
78. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase
79. Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats
80. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis
81. Apoptosis in multiple sclerosis